Third Generation Sequencing Market is Estimated To Witness High Growth Owing To Efficient Genome Sequencing Capabilities
![]() |
Third Generation Sequencing Market |
The global Third Generation Sequencing Market is
estimated to be valued at US$ 8.93 Bn in
2022 and is expected to exhibit a CAGR
of 13.1% over the forecast period 2023-2030, as highlighted in a new report
published by Coherent Market Insights.
Market Overview:
Third generation sequencing allows for real-time sequencing of long DNA
molecules without prior amplification, enabling analysis of epigenetic markers,
detection of rare mutations, and discovery of structural variations. It offers
improved read lengths over second generation sequencing platforms.
Market key trends:
One of the key trend gaining popularity in the third generation sequencing
market is long-read sequencing. Long-read sequencing provides advantage of
generating long, continuous DNA/RNA reads of up to 100,000+ bases in length. It
simplifies sequence assembly and structural variant detection. For example,
Pacific Biosciences' Single Molecule, Real-Time (SMRT) sequencing can generate
average read lengths in excess of 10kb, helping assemble genomes with greater
accuracy and resolve complex structural variations that were difficult to
elucidate before.
Segment Analysis
The Third
Generation Sequencing Market generation
sequencing market is segmented into single-molecule real-time sequencing
(SMRT), nanopore sequencing and synthesis sequencing. Among these, the
single-molecule real-time sequencing (SMRT) segment currently dominates the
third generation sequencing market as it is capable of producing long reads up
to hundreds of kilobases. SMRT can sequence full bacterial and viral genomes
and identify structural variants and large haplotypes. This has led to its
wider adoption in applications like genome assembly and long-read sequencing
projects across academic research and clinical diagnostics.
Key Takeaways
The global third generation sequencing market is expected to witness high
growth, exhibiting CAGR of 13.1%
over the forecast period, due to increasing demand for real-time, long-read and
affordable sequencing. The market size is expected to reach US$ 24.2 Bn by 2030.
From a regional perspective, North America is expected to dominate the third
generation sequencing market during the forecast period. This is attributed to
high adoption of advanced sequencing technologies, strong presence of industry
players and increasing R&D investments in the region.
Key players operating in the third generation sequencing market are Pacific
Biosciences of California, Inc., Oxford Nanopore Technologies, Ltd., BGI
Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher
Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop
Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC
Biotech AG, Phase Genomics, Inc. The market players are focusing on new product
launches, partnerships and geographic expansions to gain market share.
Read More : https://www.rapidwebwire.com/third-generation-sequencing-market-analysis-forecast-trends-demand/
Comments
Post a Comment